Found an issue? Give us feedback

Frontiers in Neurolo...arrow_drop_down

Frontiers in Neurology

2017 . Peer-reviewed

Data sources: Frontiers

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Cannabis and Multiple Sclerosis—The Way Forward

Name: Cannabis and Multiple Sclerosis—The Way Forward
Keywords: cannabis, National Institutes of Health (U.S.), multiple sclerosis, marijuana, observational research, Neuroscience

appsOther research product23 Jun 2017 English Publisher:Frontiers Media S.A.

Authors: Rudroff, Thorsten; Honce, Justin M.;

Cannabis and Multiple Sclerosis—The Way Forward

- Summary
- Subjects
- References
  (16)
- Metrics

Related Organizations

View all View all

Keywords

cannabis, National Institutes of Health (U.S.), multiple sclerosis, marijuana, observational research, Neuroscience

16 references, page 1 of 2

1 Cofield SS Salter AR Tyra T McNeal S Cutter G Marrie RA Current marijuana usage by multiple sclerosis status and disability in the NARCOMS registry. Int J Mult Scler Care (2015) 17(Suppl 1):6.10.7224/1537-2073-17.s1.1 [OpenAIRE] [DOI]

2 Chong MS Wolff K Wise K Tanton C Winstock A Silber E. Cannabis use in patients with multiple sclerosis. Mult Scler (2006) 12:646–51.10.1177/1352458506070947 17086912 [OpenAIRE] [PubMed] [DOI]

3 Kindred JH Li K Ketelhut NB Proessl F Shaffer WR Fling BW Cannabis use and neurological disability. First Annual International Multidisciplinary Cannabis Research Conference. Pueblo: CSU Pueblo (2017).

4 Wade DT Makela P Robson P House H Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler (2004) 10:343–441.10.1191/1352458504ms1082oa [OpenAIRE] [DOI]

5 Rog DJ Nurmikko TJ Friede T Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology (2005) 27:812–9.10.1212/01.wnl.0000176753.45410.8b 16186518 [OpenAIRE] [PubMed] [DOI]

6 Koppel BS Brust JCM Fife T Bronstein J Youssof S Gronseth G Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders. Neurology (2014) 82:1556–63.10.1212/WNL.0000000000000363 [DOI]

7 Zajicek J Fox P Sanders H Wright D Vickery J Nunn A Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet (2003) 362:1517–26.10.1016/S0140-6736(03)14738-1 14615106 [OpenAIRE] [PubMed] [DOI]

8 Ball S Vickery J Hobart J Wright D Green C Shearer J The cannabinoid use in progressive inflammatory brain disease (CUPID) trial: a randomised double blind placebo-controlled parallel-group multicentre trial and economic evaluation of ca nnabinoids to slow progression in multiple sclerosis. Health Technol Assess (2015) 19:12.10.3310/hta19120 [OpenAIRE] [DOI]

9 Zajicek J Ball S Wright D Vickery J Nunn A Miller D Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial. Lancet Neurol (2013) 12:857–65.10.1016/S1474-4422(13)70159-5 23856559 [OpenAIRE] [PubMed] [DOI]

10 U.S. Department of Health and Human Services, National Institutes of Health. NIH Reporter. (2017). Available from: https://projectreporter.nih.gov/reporter.cfm

chevron_left
1
2
chevron_right

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

Found an issue? Give us feedback

Average

Related to Research communities

Knowmad Institut

Neuroinformatics

Neuroscience